Linda Wagner-Weiner Selected Research

chlorotriphenylsilane (CTPS)

1/2022	Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
10/2018	Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
3/2012	Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linda Wagner-Weiner Research Topics

Disease

5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 01/2018
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2014 - 04/2009
3	Vasculitis (Vasculitides) 01/2022 - 08/2017
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 10/2019 - 01/2017
2	Lupus Nephritis 10/2018 - 03/2012
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022
1	Microscopic Polyangiitis 01/2022
1	Infections 01/2021
1	Macrophage Activation Syndrome 10/2019
1	Shock 10/2019
1	Autoimmune Diseases (Autoimmune Disease) 02/2019
1	Catatonia 02/2019
1	Encephalitis (Encephalitis, Rasmussen) 02/2019
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 02/2019
1	Dermatomyositis (Dermatopolymyositis) 01/2017
1	Hemorrhage 10/2016
1	Pain (Aches) 06/2015
1	Anemia 06/2015
1	Inflammation (Inflammations) 06/2015
1	Atherosclerosis 03/2014
1	Osteoporosis 01/2014
1	Metabolic Bone Diseases (Osteopenia) 01/2014
1	Disease Progression 01/2013
1	Proteinuria 05/2009

Drug/Important Bio-Agent (IBA)

3	chlorotriphenylsilane (CTPS)IBA 01/2022 - 03/2012
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 08/2017
2	GlucocorticoidsIBA 01/2021 - 01/2014
2	Intravenous Immunoglobulins (IVIG)FDA Link 10/2019 - 01/2017
2	Rituximab (Mabthera)FDA Link 02/2019 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2018
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2019
1	AntibodiesIBA 02/2019
1	BenzodiazepinesIBA 02/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2019
1	N-Methylaspartate (NMDA)IBA 02/2019
1	S100A12 ProteinIBA 01/2019
1	Oxygen (Dioxygen)IBA 10/2016
1	Antinuclear AntibodiesIBA 06/2015
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2015
1	C-Reactive ProteinIBA 03/2014
1	oxidized low density lipoproteinIBA 03/2014
1	LDL CholesterolIBA 03/2014
1	Atorvastatin (Lipitor)FDA Link 03/2014
1	SteroidsIBA 01/2014
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2014
1	Diphosphonates (Bisphosphonates)IBA 01/2014
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Prednisone (Sone)FDA LinkGeneric 05/2009
1	Azathioprine (Imuran)FDA LinkGeneric 05/2009
1	CreatinineIBA 05/2009
1	Lipoprotein(a)IBA 05/2009
1	Interleukin-1 Receptor-Associated KinasesIBA 04/2009

Therapy/Procedure

6	Therapeutics 02/2019 - 03/2012
1	Plasmapheresis 02/2019